A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Phendimetrazine
Chromium nicotinate
Potassium may increase the excretion rate of Chromium nicotinate which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Chromium gluconate
Potassium may increase the excretion rate of Chromium gluconate which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Chromic nitrate
Potassium may increase the excretion rate of Chromic nitrate which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Chromic citrate
Potassium may increase the excretion rate of Chromic citrate which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Lithium carbonate
Potassium may increase the excretion rate of Lithium carbonate which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Lithium citrate
Potassium may increase the excretion rate of Lithium citrate which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Lithium hydroxide
Potassium may increase the excretion rate of Lithium hydroxide which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Pentetic acid
Potassium may increase the excretion rate of Pentetic acid which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Patent Blue
Potassium may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Bismuth subgallate
Potassium may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Albutrepenonacog alfa
Potassium may increase the excretion rate of Albutrepenonacog alfa which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Fenofibric acid
Potassium may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Almasilate
Potassium may increase the excretion rate of Almasilate which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Ipecac
Potassium may increase the excretion rate of Ipecac which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Dichlorobenzyl alcohol
Potassium may increase the excretion rate of Dichlorobenzyl alcohol which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Phosphocreatine
Potassium may increase the excretion rate of Phosphocreatine which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Oxabolone cipionate
Potassium may increase the excretion rate of Oxabolone cipionate which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Inosine pranobex
Potassium may increase the excretion rate of Inosine pranobex which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Nedaplatin
Potassium may increase the excretion rate of Nedaplatin which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Tiapride
Potassium may increase the excretion rate of Tiapride which could result in a lower serum level and potentially a reduction in efficacy.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3